Evolusi Toxic Positivity dalam Penelitian Kesehatan Mental

Main Article Content

Apriyanto Apriyanto
Lilik Hidayati

Abstract

Fenomena toxic positivity, yakni dorongan berlebihan untuk mempertahankan pandangan positif di segala situasi, telah menjadi perhatian penting dalam kajian kesehatan mental. Studi ini bertujuan untuk memetakan evolusi penelitian tentang toxic positivity menggunakan analisis bibliometrik berbasis data dari Scopus. Dengan menggunakan perangkat VOSviewer, penelitian ini menganalisis tren publikasi, jaringan kolaborasi penulis, serta tema-tema utama yang berkembang dari waktu ke waktu. Hasilnya menunjukkan bahwa toxic positivity berkorelasi erat dengan isu-isu seperti tekanan emosional, kesehatan mental tenaga medis, budaya media sosial, dan upaya pengembangan intervensi alternatif seperti biofeedback. Selain itu, ditemukan bahwa penyebaran toxic positivity diperkuat oleh dinamika sosial di era digital, yang mendorong norma kebahagiaan palsu melalui platform daring. Studi ini menegaskan pentingnya pendekatan interdisipliner dalam memahami toxic positivity dan menyerukan pengembangan strategi literasi emosional yang lebih inklusif dan berbasis empati dalam praktik kesehatan mental. Implikasi praktisnya mencakup perlunya perubahan pada tingkat individu, komunitas, dan institusi untuk mendukung ekspresi emosional yang sehat dan otentik.

Article Details

How to Cite
Apriyanto, A., & Hidayati, L. (2025). Evolusi Toxic Positivity dalam Penelitian Kesehatan Mental. Sanskara Ilmu Sosial Dan Humaniora, 2(02), 94–105. https://doi.org/10.58812/sish.v2i02.547
Section
Articles

References

Abubakar, I., Drobniewski, F., Southern, J., Sitch, A. J., Jackson, C., Lipman, M., Deeks, J. J., Griffiths, C., Bothamley, G., & Lynn, W. (2018). Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study. The Lancet Infectious Diseases, 18(10), 1077–1087.

Ansell, S. M., Lesokhin, A. M., Borrello, I., Halwani, A., Scott, E. C., Gutierrez, M., Schuster, S. J., Millenson, M. M., Cattry, D., & Freeman, G. J. (2015). PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma. New England Journal of Medicine, 372(4), 311–319.

BERMEJO, M. S., ELEAZAR, E. C., QUINTO, K. L. M., & VILLAREZ, A. L. (2021). TOXIC POSITIVITY AND ITS ROLE ON COLLEGE STUDENTS’MENTAL HEALTH DURING THE COVID-19 PANDEMIC. Doctoral dissertation, Rizal Technological University]. DOI: 10.13140/RG. 2 ….

Bhattacharyya, R., Bhattacharyya, M. N., & Sharaff, M. S. (2021). Toxic Positivity and Mental Health–It is ok to Not Be ok. Design Engineering, 5109–5127.

Coudert, A. P. (2022a). 8 ‘Toxic Positivity.’ Religious Dimensions of Conspiracy Theories: Comparing and Connecting Old and New Trends.

Coudert, A. P. (2022b). ‘Toxic Positivity’: From New Thought to Donald Trump. In Religious Dimensions of Conspiracy Theories (pp. 142–164). Routledge.

de Rijk, S. J. (2025). Toxic Positivity and Epistemic Injustice. Episteme, 1–17.

Donthu, N., Kumar, S., Mukherjee, D., Pandey, N., & Lim, W. M. (2021). How to conduct a bibliometric analysis: An overview and guidelines. Journal of Business Research, 133, 285–296.

Feltner, M. E. (2023). Toxic positivity and perceptions of mental health.

Garner, C. (n.d.). Toxic Positivity.

Gold, L. S., Bernstein, L., Magaw, R., & Slone, T. H. (1989). Interspecies extrapolation in carcinogenesis: prediction between rats and mice. Environmental Health Perspectives, 81, 211–219.

Jain, A., Tamarana, R., Santosh, U., & Singh, R. (2024). Relationship between Dominating Personalities and Toxic Positivity: Mediating Roles of Intrapersonal and Interpersonal Control. Journal of the Indian Academy of Applied Psychology, 50(1), 186–195.

Kaufman, S. B. (2021). The opposite of toxic positivity. The Atlantic, 18.

Lecompte-Van Poucke, M. (2022). ‘You got this!’: A critical discourse analysis of toxic positivity as a discursive construct on Facebook. Applied Corpus Linguistics, 2(1), 100015.

Lew, Z., & Flanagin, A. J. (2023). Toxic positivity on social media: The drawbacks and benefits of sharing positive (but potentially platitudinous) messages online. New Media & Society, 14614448231213944.

Park, W., Yoo, D. H., Miranda, P., Brzosko, M., Wiland, P., Gutierrez-Ureña, S., Mikazane, H., Lee, Y.-A., Smiyan, S., & Lim, M.-J. (2017). Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study. Annals of the Rheumatic Diseases, 76(2), 346–354.

Putra, R. P., Ramadhanti, A., & Rizky, D. A. (2023). Gender differences in levels of toxic positivity in adolescents: a quantitative study. Jurnal Ilmiah Ilmu Terapan Universitas Jambi, 7(2), 83–91.

Putra, R. P., Ramadhanti, A., Sasanti, A., Fadil, A., & Salsyabila, N. (2023). Toxic positivity in adolescents: An attitude of always being positive in every situation. Journal of Psychology and Instruction, 7(1), 11–21.

Rubnitz, J. E., Inaba, H., Dahl, G., Ribeiro, R. C., Bowman, W. P., Taub, J., Pounds, S., Razzouk, B. I., Lacayo, N. J., & Cao, X. (2010). Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. The Lancet Oncology, 11(6), 543–552.

Salopek, A. H., & Eastin, M. S. (2024). Toxic positivity intentions: an image management approach to upward social comparison and false self-presentation. Journal of Computer-Mediated Communication, 29(3), zmae003.

Savige, J., Davies, D., Falk, R. J., Jennette, J. C., & Wiik, A. (2000). Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney International, 57(3), 846–862.

Shipp, H. G., & Hall, K. C. (2024). Analyzing the concept of toxic positivity for nursing: A dimensional analysis approach. Journal of Advanced Nursing, 80(8), 3146–3157.

Snediker, V., Ramirez-Fuentes, J., Villa Arreguin, S., Hobbs, M., & McChesney, J. (2024). Developing a Measure of Toxic Positivity at Work.

Spierings, D. C., de Vries, E. G., Vellenga, E., van den Heuvel, F. A., Koornstra, J. J., Wesseling, J., Hollema, H., & de Jong, S. (2004). Tissue distribution of the death ligand TRAIL and its receptors. Journal of Histochemistry & Cytochemistry, 52(6), 821–831.

Suresh, A. K., Pelletier, D. A., Wang, W., Morrell-Falvey, J. L., Gu, B., & Doktycz, M. J. (2012). Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types. Langmuir, 28(5), 2727–2735.

Swift, J. (2021). Toxic Positivity? Rethinking Respectability, Revaluing Pleasure. South Atlantic Quarterly, 120(3), 591–608.

Upadhyay, I. S., Srivatsa, K. V. A., & Mamidi, R. (2022). Towards toxic positivity detection. Proceedings of the Tenth International Workshop on Natural Language Processing for Social Media, 75–82.

von Eiff, C., Friedrich, A. W., Peters, G., & Becker, K. (2004). Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus. Diagnostic Microbiology and Infectious Disease, 49(3), 157–162.

Wibowo, R. S. (2020). The Answers Are Not Always Optimism: Overcoming Toxic Positivity During COVID-19 Outbreak. Sustainability, 4(1), 1–10.

Wyatt, Z. (2024). The Dark Side of# PositiveVibes: Understanding Toxic Positivity in Modern Culture. Psychiatry.

Wynes, M. W., Sholl, L. M., Dietel, M., Schuuring, E., Tsao, M. S., Yatabe, Y., Tubbs, R. R., & Hirsch, F. R. (2014). An international interpretation study using the ALK IHC antibody D5F3 and a sensitive detection kit demonstrates high concordance between ALK IHC and ALK FISH and between evaluators. Journal of Thoracic Oncology, 9(5), 631–638.